A Montreal study raises questions about even short-term use of the pain drug Vioxx and may harm Merck & Co.'s defense against 11,500 lawsuits, a report said.
The study, published Tuesday in the Canadian Medical Association Journal, said people 65 and older are at the greatest risk of suffering a heart attack within 6-13 days of their first ingestion of Vioxx.
The McGill University study also found elderly patients' heart attack risk did not increase the longer they took the drug, which Merck pulled off the world market in 2004.
A key element of Merck's defense has been that it took 18 months or longer for the heart attack risk to increase, The Wall Street Journal reported.
Reacting to the study, Merck said its strategy was unchanged "and we continue to believe those (short-term) cases have no merit," said lawyer Ted Mayer.
However, plaintiffs' lawyer Andy Birchfield said the study "strengthens our hand tremendously."
"From the very beginning, we have said it doesn't take 18 months," Birchfield said.
Copyright 2006 by United Press International
Related stories:
FDA to review Vytorin results
The U.S. Food and Drug Administration said it is conducting a review of the cholesterol drug Vytorin based on preliminary results from a recent study.
Vioxx appeal to go before New Jersey court
The New Jersey Supreme Court reportedly has agreed to hear Merck & Co.'s appeal of the class certification of a Vioxx lawsuit.
Novel imaging approach may assist in predicting success of treatment for atrial fibrillation
University of Utah researchers have developed a magnetic resonance imaging (MRI)-based method for detecting and quantifying injury to the wall of the heart's left atrium in patients who have undergone a procedure to treat atrial fibrillation. The results of the study are published in the Oct. 7, 2008, issue of the
Journal of the American College of Cardiology.
Pneumococcal vaccine associated with 50 percent lower risk of heart attacks
Pneumococcal (pneumonia) vaccination was associated with a 50% lower risk of heart attacks 2 years after vaccination, suggests a large hospital-based case-control study published in
CMAJ.
Computer hardware 'guardians' protect users from undiscovered bugs
As computer processor chips grow faster and more complex, they are likely to make it to market with more design bugs. But that may be OK, according to University of Michigan researchers who have devised a system that lets chips work around all functional bugs, even those that haven't been detected.
War from the ground up
The connection between geology and the history of the Civil War has fascinated Robert Whisonant since his undergraduate days, and now Whisonant has teamed up with geomorphologist Judy Ehlen, both of Radford University, to take history, military history in particular, a step deeper -- into the geology beneath the soldiers' feet.
Computer hardware 'guardians' protect users from undiscovered bugs
(PhysOrg.com) -- As computer processor chips grow faster and more complex, they are likely to make it to market with more design bugs. But that may be OK, according to University of Michigan researchers who have devised a system that lets chips work around all functional bugs, even those that haven't been detected.
Restless nights put older adults at risk for depression recurrence
Nearly 60 percent of the nation's elderly have trouble sleeping, whether it's a lot of tossing and turning or outright bouts of insomnia. While for most people sleeplessness can be annoying at best or unhealthy at worst, for elderly individuals who have suffered from depression in the past, poor sleep may be the first sign that a new bout of depression is coming on.